Report overview
This report contains market size and forecasts of Necrotizing Autoimmune Myositis in Global, including the following market information:
Global Necrotizing Autoimmune Myositis Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Necrotizing Autoimmune Myositis market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Steroids Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Necrotizing Autoimmune Myositis include GlaxoSmithKline plc, Dr. Reddy's Laboratories, Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.), Hetero Drugs Limited, AbbVie Inc., Teva Pharmaceutical Industries and Novartis AG, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Necrotizing Autoimmune Myositis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Necrotizing Autoimmune Myositis Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Necrotizing Autoimmune Myositis Market Segment Percentages, by Type, 2022 (%)
Steroids
Immunosuppressant
Others
Global Necrotizing Autoimmune Myositis Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Necrotizing Autoimmune Myositis Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Others
Global Necrotizing Autoimmune Myositis Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Necrotizing Autoimmune Myositis Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Necrotizing Autoimmune Myositis revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Necrotizing Autoimmune Myositis revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline plc
Dr. Reddy's Laboratories
Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.)
Hetero Drugs Limited
AbbVie Inc.
Teva Pharmaceutical Industries
Novartis AG
